The latest reporting and analysis on breakthroughs in Parkinson's research and issues that matter most to you.
September 20, 2017
How does dyskinesia impact people with PD? An MJFF-funded measurement scale captured those perceptions and helped a new drug get approved to treat it.
September 19, 2017
Recent study finds that virtual visits are just as effective as in-person doctors' appointments for people with PD.
September 18, 2017
The videos enable people with Parkinson's to learn more about PD on their own terms.
September 15, 2017
In honor of Dystonia Awareness Month, a guest blogger shares his journey living with the third most common movement disorder and participating in research.
September 14, 2017
In this video, Dr. Dolhun talks about a common side effect of levodopa and how it can be managed.
September 13, 2017
Following the recent FDA approval of a new medication to treat dyskinesia, Rachel Dolhun, MD, discusses considerations for patients around new therapies.
A Clinician's Perspective on Parkinson's 360: "Patients are grateful for the straightforward, positive and frank information"
September 13, 2017
Rachel Dolhun, MD, talks with a clinician about how Parkinson's 360 has supported her patients through relatable stories and tools for living well with Parkinson's disease.
September 12, 2017
Researchers from 23andMe, Genentech and National Institute on Aging looked at DNA from 425,000 volunteers. These findings could lead to development of new drugs to stop PD.
September 11, 2017
Lawmakers have three additional months to negotiate federal funding levels, including money for Parkinson's research.
September 08, 2017
One MJFF staffer climbed Mt. Kilimanjaro to combine a love of adventure with a commitment to cure Parkinson's. Along the way, she discovered the power of the PD community.